The Medicines and Healthcare products Regulatory Agency (MHRA) and Commission on Human Medicines are establishing a new Code of Practice governing conflicts of interest and conduct for expert advisory committees. The code addresses the function, purpose, and relevant interests of MHRA advisory committees through consultation and formal recommendations. Status is active with recent consultation responses being analysed.
In response to: Consultation on a new Code of Practice for the Expert Advisory Committees
In response to: Consultation on a new Code of Practice for the Expert Advisory Committees
In response to: Consultation on a new Code of Practice for the Expert Advisory Committees
In response to: Consultation on a new Code of Practice for the Expert Advisory Committees
In response to: Consultation on a new Code of Practice for the Expert Advisory Committees
In response to: Consultation on a new Code of Practice for the Expert Advisory Committees
We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts providing the …
We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts providing the …
We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts providing the …